Average Co-Inventor Count = 4.26
ph-index = 17
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Janssen Pharmaceutica Nv (49 from 2,078 patents)
2. Astex Therapeutics Limited (14 from 123 patents)
3. Other (2 from 832,880 patents)
4. Janssen Sciences Ireland Unlimited Company (61 patents)
65 patents:
1. 11396517 - Exo-aza spiro inhibitors of menin-MLL interaction
2. 11130751 - Quinoxaline and pyridopyrazine derivatives as PI3K-beta inhibitors
3. 10745409 - Azepane inhibitors of menin-MLL interaction
4. 10519137 - Pyrazolyl quinoxaline kinase inhibitors
5. 10272087 - Pteridines as FGFR inhibitors
6. 10039759 - Quinolines as FGFR kinase modulators
7. 9856236 - Substituted quinoxalines as FGFR kinase inhibitors
8. 9850228 - Pyrazolyl quinoxaline kinase inhibitors
9. 9757364 - Naphthyridine derivative compounds
10. 9737544 - Compounds
11. 9493426 - Quinazolinone derivatives useful as FGFR kinase modulators
12. 9464071 - Pyrazolyl quinoxaline kinase inhibitors
13. 9447098 - Pteridines as FGFR inhibitors
14. 9303030 - Compounds
15. 9290478 - Substituted quinoxalines as FGFR kinase inhibitors